Pharmacology, Toxicology and Pharmaceutical Science
Aprepitant
100%
Antiemetic Agent
94%
Adverse Drug Reaction
83%
Malignant Neoplasm
78%
Adverse Event
71%
Granisetron
70%
Chemotherapy
66%
Bendamustine
66%
Adverse Event
62%
Hematologic Malignancy
43%
Dexamethasone
43%
Chemotherapy Induced Nausea and Vomiting
43%
Palonosetron
42%
Paclitaxel
41%
Malignant Neoplasm
40%
Omeprazole
35%
Bortezomib
34%
Carfilzomib
34%
Oxaliplatin
33%
Disproportionality Analysis
33%
Polypharmacy
33%
Naldemedine
28%
Advanced Cancer
28%
Lenalidomide
26%
Ixazomib
26%
Pharmacotherapy
26%
Cyclophosphamide
25%
Community Pharmacy
25%
Proteasome Inhibitor
24%
Drug
23%
Irradiation
22%
Cancer Chemotherapy
22%
Nivolumab
22%
Proton Pump Inhibitor
22%
Idarubicin
22%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
22%
Constipation
22%
Rodent
22%
Capecitabine
22%
Juvenile Rheumatoid Arthritis
22%
Hand Foot Syndrome
22%
Pharmacology
22%
Narcotic Agent
22%
Hypocalcemia
22%
Bortezomib
22%
Drug Information
22%
Skin Toxicity
22%
Ponatinib
22%
Pomalidomide
22%
Leukemia
22%
Medicine and Dentistry
Adverse Event
70%
Bendamustine
45%
Patient
43%
Proton-Pump Inhibitor
38%
Allogeneic Hematopoietic Stem Cell Transplantation
35%
Odds Ratio
22%
Non Small Cell Lung Cancer
22%
Whole Body Radiation
22%
Tacrolimus
22%
Hand Foot Syndrome
22%
Capecitabine
22%
Bortezomib
22%
Aprepitant
22%
Low Drug Dose
22%
Drug Therapy
22%
Febrile Neutropenia
22%
Pediatrics
22%
Mycophenolate Mofetil
22%
Mechanical Allodynia
22%
Kidney Graft
22%
Cyclophosphamide
22%
Observational Study
22%
Docetaxel
22%
Kidney Function
22%
Association
20%
Analysis
19%
Oxaliplatin
18%
Paclitaxel
18%
Chemotherapy
18%
Oral Drug Administration
18%
Dermatosis
15%
Cold Hyperalgesia
15%
Odds Ratio
15%
Oncology
14%
Symptom
13%
Platelet
13%
Omeprazole
12%
Acute Graft Versus Host Disease
12%
Duloxetine
11%
Cytomegalovirus Infection
11%
Peripheral Neuropathy
11%
Malignant Neoplasm
11%
Adverse Drug Reaction
10%
Intravenous Drug Administration
10%
Age
10%
Disseminated Herpes Zoster
10%
Exanthem
10%
Female
10%
Incidence
9%
Adverse Drug Reaction
9%